{
     "PMID": "28646794",
     "OWN": "NLM",
     "STAT": "In-Process",
     "LR": "20170826",
     "IS": "2213-2317 (Electronic) 2213-2317 (Linking)",
     "VI": "13",
     "DP": "2017 Oct",
     "TI": "Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways.",
     "PG": "345-352",
     "LID": "S2213-2317(17)30282-3 [pii] 10.1016/j.redox.2017.06.003 [doi]",
     "AB": "The aim of the present study is to elucidate the neuronal pathways associated to NSAIDs causing a reduction of the risk and progression of Alzheimer's disease. The research was developed administering the active enantiomer of ibuprofen, dexibuprofen (DXI), in order to reduce associated gastric toxicity. DXI was administered from three to six-month-old female APPswe/PS1dE9 mice as a model of familial Alzheimer's disease. DXI treatment reduced the activation of glial cells and the cytokine release involved in the neurodegenerative process, especially TNFalpha. Moreover, DXI reduced soluble beta-amyloid (Abeta1-42) plaque deposition by decreasing APP, BACE1 and facilitating Abeta degradation by enhancing insulin-degrading enzyme. DXI also decreased TAU hyperphosphorylation inhibiting c-Abl/CABLES/p-CDK5 activation signal pathway and prevented spatial learning and memory impairment in transgenic mice. Therefore, chronic DXI treatment could constitute a potential AD-modifying drug, both restoring cognitive functions and reversing multiple brain neuropathological hallmarks.",
     "CI": [
          "Copyright (c) 2017 The Authors. Published by Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Ettcheto, Miren",
          "Sanchez-Lopez, Elena",
          "Pons, Laura",
          "Busquets, Oriol",
          "Olloquequi, Jordi",
          "Beas-Zarate, Carlos",
          "Pallas, Merce",
          "Garcia, Maria Luisa",
          "Auladell, Carme",
          "Folch, Jaume",
          "Camins, Antoni"
     ],
     "AU": [
          "Ettcheto M",
          "Sanchez-Lopez E",
          "Pons L",
          "Busquets O",
          "Olloquequi J",
          "Beas-Zarate C",
          "Pallas M",
          "Garcia ML",
          "Auladell C",
          "Folch J",
          "Camins A"
     ],
     "AD": "Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia i Ciencias de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Unitats de Bioquimica i Farmacologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Tarragona, Spain; Institut de Neurociencias, University of Barcelona, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Unitat de Farmacia, Tecnologia Farmaceutica i Fisicoquimica, Facultat de Farmacia, Universitat de Barcelona, Barcelona, Spain; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia i Ciencias de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia i Ciencias de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Unitats de Bioquimica i Farmacologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Tarragona, Spain; Institut de Neurociencias, University of Barcelona, Spain. Instituto de Ciencias Biomedicas, Facultad de Ciencias de la Salud, Universidad Autonoma de Chile, Talca, Chile. Laboratorio de Regeneracion y Desarrollo Neural, Instituto de Neurobiologia, Departamento de Biologia Celular y Molecular, CUCBA, Universidad de Guadalajara, Jalisco, Mexico. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia i Ciencias de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Institut de Neurociencias, University of Barcelona, Spain. Unitat de Farmacia, Tecnologia Farmaceutica i Fisicoquimica, Facultat de Farmacia, Universitat de Barcelona, Barcelona, Spain; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Spain. Departament de Biologia Cellular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain. Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Unitats de Bioquimica i Farmacologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Tarragona, Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia i Ciencias de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Institut de Neurociencias, University of Barcelona, Spain. Electronic address: camins@ub.edu.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170615",
     "PL": "Netherlands",
     "TA": "Redox Biol",
     "JT": "Redox biology",
     "JID": "101605639",
     "PMC": "PMC5480981",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "APPSwe/PS1dE9",
          "Alzheimer's disease",
          "Dexibuprofen",
          "Hippocampus",
          "Insulin receptor",
          "Memory impairment",
          "Mitochondria",
          "TAU"
     ],
     "EDAT": "2017/06/25 06:00",
     "MHDA": "2017/06/25 06:00",
     "CRDT": [
          "2017/06/25 06:00"
     ],
     "PHST": [
          "2017/04/14 00:00 [received]",
          "2017/06/06 00:00 [revised]",
          "2017/06/13 00:00 [accepted]",
          "2017/06/25 06:00 [pubmed]",
          "2017/06/25 06:00 [medline]",
          "2017/06/25 06:00 [entrez]"
     ],
     "AID": [
          "S2213-2317(17)30282-3 [pii]",
          "10.1016/j.redox.2017.06.003 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Redox Biol. 2017 Oct;13:345-352. doi: 10.1016/j.redox.2017.06.003. Epub 2017 Jun 15.",
     "term": "hippocampus"
}